TOP TIERMARKET NEWSWIRE
News & sentiment

STOKE THERAPEUTICS I (STOK) — News & AI sentiment

STOKE THERAPEUTICS I (STOK) news roundup. 1 story in the past week, 14 over 30 days. Average 30-day sentiment is 60.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $1.1M — net selling of $1.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 56/100
30d stories
14
avg sentiment 60.4/100
Insider net (90d)
$1.1M
0 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

STOK news in the last 24 hours, 7 days, 30 days and 90 days

How much STOK coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSTOK storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days156/100STOK headlines →
Last 30 days1460.4/100STOK headlines →
Last 90 days3257.3/100STOK headlines →

Latest stories on STOK

3d ago
Sep 3
Sep 3
Sep 3
Sep 2
Sep 1
Sep 1
Sep 1
Sep 1
Aug 21
Aug 21
Aug 21
Why is Stoke Therapeutics stock gaining today?
Investing.com Markets50 · neutralgeneral
Aug 21
Aug 18
Aug 11
Aug 8
Aug 5
Aug 5
Canaccord lowers Stoke Therapeutics stock price target to $58
Investing.com Analyst Ratings44 · neutralanalyst
Aug 4
Aug 4
Aug 4
Aug 3
Aug 3
Aug 3
Jul 27
Open STOK in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →